PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 16 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A randomized controlled open clinical trial evaluated its efficacy in managing iron deficiency anemia [PMID:27313416].
A randomized controlled trial tested its influence on UVC-induced DNA strand break repair, nucleotide excision repair, and constitutive base excision repair in healthy aged individuals [PMID:27364038].
Intervention improved learning and memory and increased neuronal metabolic activity in AbPP-PS1 mice [PMID:29358550].
Improved cardiac function in aging rats and decreased left ventricular hypertrophy in aorta-constricted rats [PMID:28819266].
Possesses significant immunostimulant activity and moderate cytoprotective activity against cyclophosphamide immunosuppression [PMID:24167334].
Dosage & administration
Evidence summary
PubMed sources
- 1.PMID: 27364038 (2016) — Effect of Amalaki rasayana on DNA damage and repair in randomized aged human individuals. · Journal of ethnopharmacology
- 2.PMID: 24167334 (2012) — Immunomodulatory activity of Āmalaki Rasāyana: An experimental evaluation. · Ancient science of life
- 3.PMID: 22606337 (2012) — In vivo effects of traditional Ayurvedic formulations in Drosophila melanogaster model relate with therapeutic applications. · PloS one
- 4.PMID: 28602428 (2017) — Influence of Amalaki Rasayana on telomerase activity and telomere length in human blood mononuclear cells. · Journal of Ayurveda and integrative medicine
- 5.PMID: 27313416 (2015) — Clinical efficacy of Amalaki Rasayana in the management of Pandu (Iron deficiency anemia).